Your browser doesn't support javascript.
loading
Hematological prognosticators in metastatic renal cell cancer treated with immune checkpoint inhibitors: a meta-analysis.
Yanagisawa, Takafumi; Mori, Keiichiro; Katayama, Satoshi; Mostafaei, Hadi; Quhal, Fahad; Laukhtina, Ekaterina; Rajwa, Pawel; Motlagh, Reza S; Aydh, Abdulmajeed; König, Frederik; Grossmann, Nico C; Pradere, Benjamin; Miki, Jun; Schmidinger, Manuela; Egawa, Shin; Shariat, Shahrokh F.
Afiliación
  • Yanagisawa T; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.
  • Mori K; Department of Urology, The Jikei University School of Medicine, Tokyo105-8461, Japan.
  • Katayama S; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.
  • Mostafaei H; Department of Urology, The Jikei University School of Medicine, Tokyo105-8461, Japan.
  • Quhal F; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.
  • Laukhtina E; Department of Urology, Okayama University Graduate School of Medicine, Dentistry & Pharmaceutical Sciences, Okayama, 700-8558, Japan.
  • Rajwa P; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.
  • Motlagh RS; Research Center for Evidence Based Medicine, Tabriz University of Medical Sciences, Tabriz, 5166, Iran.
  • Aydh A; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.
  • König F; Department of Urology, King Fahad Specialist Hospital, Dammam, 32253, Saudi Arabia.
  • Grossmann NC; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.
  • Pradere B; Institute for Urology & Reproductive Health, Sechenov University, Moscow, 119991, Russia.
  • Miki J; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.
  • Schmidinger M; Department of Urology, Medical University of Silesia, Zabrze, 41-808, Poland.
  • Egawa S; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, 1090, Austria.
  • Shariat SF; Men's Health & Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Immunotherapy ; 14(9): 709-725, 2022 06.
Article en En | MEDLINE | ID: mdl-35465726
Identifying the predictive/prognostic factors that can be applied to daily clinical practice is mandatory to facilitate the use of immune checkpoint inhibitors. Some pretreatment hematological markers used in daily clinical practice appear to be prognostic factors in metastatic renal cell carcinoma patients treated with immune checkpoint inhibitors. We believe that the findings of the present meta-analysis might help researchers to design prospective correlative biomarker studies to guide clinical decision-making in the immunotherapy era.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Diagnostic_studies / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Immunotherapy Asunto de la revista: ALERGIA E IMUNOLOGIA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Austria Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Diagnostic_studies / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Immunotherapy Asunto de la revista: ALERGIA E IMUNOLOGIA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Austria Pais de publicación: Reino Unido